The University of Florida Department of Urology invites you to attend
Grand Rounds
“What’s new in the management of biochemically recurrent prostate cancer?”
Russell Terry, MD
Department of Urology
University of Florida
Wednesday, November 8, 2017
7:00 am
Department of Urology Conference Room, M2-203C
Learning Objectives
Define biochemical recurrence of prostate cancer (BCR)
Understand the clinical implications of BCR
Have a functional knowledge of guideline-based management of BCR including treatments, risks, and benefits
Be aware of emerging diagnostic and treatment modalities for patients with BCR
Target Audience
Urologists, Residents, Nurses, Physician Assistants, and Staff
Accreditation
The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education for physicians.
Credit
The University of Florida College of Medicine designates this live activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Support
The Department of Urology within the University of Florida’s College of Medicine is hosting this free event, which is internally supported.
Contact Information
If you have any questions please feel free to contact Stephanie Stenner at Stephanie.stenner@urology.ufl.edu.
Disclosure
Dr. Terry has disclosed that she has no relevant financial relationships. Dr. Vincent Bird, Planning Committee, is a consultant for Boston Scientific. No one else in a position to control content has any financial relationship to disclose.
Section Number: 8119
